Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience
- 31 July 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38 (3) , 203-208
- https://doi.org/10.1016/s0037-1963(01)90011-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Whither Interferon for Myeloma and Other Hematologic Malignancies?Annals of Internal Medicine, 1996
- Intensive combined therapy for previously untreated aggressive myelomaBlood, 1992
- Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.Journal of Clinical Oncology, 1991
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Chemotherapy for multiple myelomaCancer, 1984
- Chemoimmunotherapy for multiple myelomaCancer, 1981
- Unmaintained remissions in multiple myelomaBlood, 1978
- Combination therapy for multiple myelomaCancer, 1977
- Prognostic factors in multiple myelomaCancer, 1975
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975